This effect of ZOL could be crucial for the inhibition of cancer cell metastasis in bone, as it was reported that neutralising anti-human CXCR-4 monoclonal antibody suppresses metastases in a breast-cancer model (Müller et al, 2001). This evidence concerns the gene CXCR4 and breast carcinoma.